EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Use of the Abbott i‐ STAT ®1 point of care device for hCG quantification in early pregnancy

Caroline Joyce iD, Paula M O'Shea iD, Rebecca Lynch, Seán J Costelloe iD, Tommie V McCarthy iD, John Coulter, Deirdre Hayes-Ryan iD, Keelin O'Donoghue iD

International Journal of Gynecology & Obstetrics · 2025

DOI: 10.1002/ijgo.70217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Caroline Joyce und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pregnancy Loss Research Group, Department of Obstetrics & Gynaecology, University College Cork, Cork, Ireland. Hauptthemen laut MEDLINE: Chorionic Gonadotropin, Point-of-Care Systems, Point-of-Care Testing, Pregnancy Complications. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Irish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the use of the Abbott i‐STAT®1 point‐of‐care‐test (POCT) device for measurement of human chorionic gonadotropin (hCG) to support the management of early pregnancy complications in a remote early pregnancy unit (EPU).

Methods

Women attending the EPU who required an hCG blood test were invited to take part in the study. Participants provided an additional blood sample for whole blood hCG measurement using the Abbott i‐STAT®1 analyzer. The remaining sample was sent to the hospital laboratory for hCG analysis using the Abbott Architect, the designated comparator method. Statistical analysis was performed using Analyze‐IT software.

Results

A total of 61 women were recruited, including cases of pregnancy of unknown location, ectopic pregnancy, and molar pregnancy. Fourteen hCG results that were outside the i‐STAT®1 assay's quantitative range, although still broadly concordant with laboratory hCG results, were excluded from statistical analysis. Analysis of the remaining 47 paired hCG results demonstrated strong agreement across the concentration range (4–2072 IU/L), with excellent Spearman correlation ( r = 0.99, P < 0.001). Passing‐Bablok linear regression indicated good agreement ( y = 1.18 + 0.96 x ) and Bland–Altman analysis showed a mean difference of −23.7 IU/L (−3.5%).

Conclusions

All hCG results from the i‐STAT®1 analyzer were clinically concordant with the central laboratory method, supporting its application in an EPU setting using established clinical decision thresholds. However, further verification through larger‐scale studies is necessary before the i‐STAT®1 analyzer can be integrated into clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chorionic GonadotropinPoint-of-Care SystemsPoint-of-Care TestingPregnancy ComplicationsHumansFemalePregnancyAdultPregnancy Trimester, FirstYoung AdultPregnancy, Ectopic

Stichwörter der Autor:innen

early pregnancyhuman chorionic gonadotropinpoint‐of‐care‐testingpregnancy of unknown location

Substanzen

Chorionic Gonadotropin

Autor:innen und Institutionen

  • Pregnancy Loss Research Group, Department of Obstetrics & Gynaecology, University College Cork, Cork, Ireland.
  • INFANT Research Centre, University College Cork, Cork, Ireland.
  • Department of Biochemistry & Cell Biology, University College Cork, Cork, Ireland.
  • Department of Clinical Biochemistry, Cork University Hospital, Cork, Ireland.
  • Department of Clinical Biochemistry & Diagnostic Endocrinology, The Mater Misericordiae University Hospital, Dublin, Ireland.
  • Department of Obstetrics & Gynaecology, Cork University Maternity Hospital, Cork, Ireland.

ORCID-Profile: Caroline Joyce, Paula M O'Shea, Seán J Costelloe, Tommie V McCarthy, Deirdre Hayes-Ryan, Keelin O'Donoghue

Förderung

  • Irish Research Council

Zitieren

APA

Joyce, C., O'Shea, P. M., Lynch, R., Costelloe, S. J., McCarthy, T. V., Coulter, J., Hayes-Ryan, D., & O'Donoghue, K. (2025). Use of the Abbott i‐ STAT ®1 point of care device for hCG quantification in early pregnancy. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70217

Vancouver

Joyce C, O'Shea PM, Lynch R, Costelloe SJ, McCarthy TV, Coulter J, et al. Use of the Abbott i‐ STAT ®1 point of care device for hCG quantification in early pregnancy. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70217

BibTeX
@article{Joyce2025,
  author = {Joyce, Caroline and O'Shea, Paula M and Lynch, Rebecca and Costelloe, Seán J and McCarthy, Tommie V and Coulter, John and Hayes-Ryan, Deirdre and O'Donoghue, Keelin},
  title = {Use of the Abbott i‐ STAT ®1 point of care device for hCG quantification in early pregnancy},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  doi = {10.1002/ijgo.70217}
}
Kostenlos starten →